References
- Porkka-Heiskanen T, Strecker R, et al. Adenosine: A mediator of the sleep-in-ducing effects of prolonged wakefulness. Science 1997;276:1265–1268.
- Moore KW, O'Garra A, et al. Interleukin 10 (review). Ann. Rev. Immunol. 1993;11:165–190.
- Stone TVV, Simmonds HA. Purines: Basic and Clinical Aspects. Kluwer Aca-demic Publishers, Dordecht, 1991. pp.115–136.
- Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome. A work-ing definition. Ann Intern Med 1988;108:387–389.
- Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a compre-hensive approach to its definition and study. Ann Intern Med 1994;121:953–959.
- Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired by chronic fatigue syndrome. QJM 1995;88:767–773.
- Simmonds HA, Duley JA, Davies P. Analysis of purines and pyrimidines in blood, urine and other physiological fluids. Techniques in Human Biochemical Ge-netics. Hommes FA: Wiley-Liss, NY, 1991. pp. 397–424.
- Komaroff AL, Buchwald DS. Chronic fatigue syndrome: an update. Ann Rev Med 1998;49:1–13.
- Gewitz H, Brown P, Most AS. Measurement of plasma adenosine concentra-tion: methodological and physiological considerations. Proc Soc Exp Biol Med 1987;185:93–100.
- Sabina RL, Holmes EW. Myoadenylate deaminase deficiency. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. Scriver CR et al.: McGraw-Hill, NY, 1995; pp. 1769–1780.
- Ogasawara N, Goto H, Yamada Y, et al. Deficiency of AMP deaminase in ery-throcytes. Human Genet 1987;75:15–18.
- Berg D, Berg LH, Couvaras J, et al. Chronic fatigue syndrome and/or fibro-myalgia as a variation of antiphospholipid antibody syndrome. Blood Coagulation & Fibrinolysis 1999;10:1–4.
- Rebbeck LE, Mahoney PD, DeNofrio D, et al. Common variant of AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 1999;99:1422–5.
- Behan WMH, Holt IJ, Kay DH, et al. In vitro study of muscle aerobic metabo-lism in chronic fatigue syndrome. J Chronic Fatigue Syndrome 1999; 5:3–16.